Eva Engelhardt
Fortuna: 163 716 $ al 31/07/2026
Fortuna: 163 716 $ al 31/07/2026
Ms. Eva A. Engelhardt is an Independent Director at Canatu Oyj and a President-Clinical Diagnostics Group & EVP at Bio-Rad Laboratories, Inc. She is on the Board of Directors at Canatu Oyj.
Ms. Engelhardt was previously employed as a Senior VP-Strategy & Marketing by CEPHEID.
She received her undergraduate degree from Royal Institute of Technology and a graduate degree from Royal Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/07/2026 | 503 ( 0 % ) | 163 716 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 10/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| CEPHEID | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.